Aspen Aerogels, Inc. (NYSE:ASPN) Receives Consensus Rating of “Hold” from Brokerages

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have been assigned an average rating of “Hold” from the six research firms that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $6.6667.

ASPN has been the topic of several recent research reports. Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Zacks Research raised shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. Finally, Barclays lowered their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a research report on Friday, November 7th.

Aspen Aerogels Price Performance

NYSE:ASPN opened at $3.54 on Tuesday. The business’s 50-day moving average is $3.31 and its 200 day moving average is $5.13. Aspen Aerogels has a 12 month low of $2.80 and a 12 month high of $9.78. The company has a market capitalization of $292.17 million, a P/E ratio of -0.95 and a beta of 2.99. The company has a current ratio of 3.94, a quick ratio of 3.33 and a debt-to-equity ratio of 0.28.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ASPN. Invesco Ltd. increased its stake in Aspen Aerogels by 237.9% during the fourth quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock worth $11,688,000 after acquiring an additional 2,907,558 shares during the last quarter. XTX Topco Ltd lifted its stake in shares of Aspen Aerogels by 786.1% in the 4th quarter. XTX Topco Ltd now owns 202,030 shares of the construction company’s stock valued at $572,000 after purchasing an additional 179,231 shares during the last quarter. Quadrature Capital Ltd boosted its holdings in shares of Aspen Aerogels by 248.5% in the 4th quarter. Quadrature Capital Ltd now owns 35,583 shares of the construction company’s stock worth $101,000 after purchasing an additional 25,373 shares during the period. Numerai GP LLC boosted its holdings in shares of Aspen Aerogels by 1,277.9% in the 4th quarter. Numerai GP LLC now owns 251,888 shares of the construction company’s stock worth $713,000 after purchasing an additional 233,608 shares during the period. Finally, Oxford Asset Management LLP bought a new position in shares of Aspen Aerogels during the 4th quarter valued at approximately $68,000. Institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.